Further analysis of AML samples at diagnosis revealed that ARMH1 expression not only blast-specific but the expression was also elevated in the blast cells from patients that relapsed (marked with dotted lasso) in comparison to blast cells from patients who achieved Clinical Remission (CR) (Figure 1B). The gene discussed is ARMH1; the disease is acute myeloid leukemia.